Search results
Fungal infections in the immunocompromised host are difficult to diagnose and difficult to treat successfully. The diagnosis is often missed or delayed because of the non-specific clinical features, the failure to isolate or difficulty in interpreting the presence of the fungus from routine microbiological cultures, and the limited usefulness ...
Jan 21, 2023 · Pneumocystis carinii pneumonia (PCP), now referred to as Pneumocystis jirovecii pneumonia, is a fungal infection that most commonly affects the immunocompromised and, in some cases, can be severely life-threatening. Typically, patients at risk are those with underlying disease states that alter host immunity, such as cancer, HIV, transplant recipients, or those taking immunosuppressive ...
Oct 12, 2021 · In immunocompromised patients, Candida is frequently isolated from respiratory samples (sputum or bronchoalveolar lavage [BAL]), though it should be interpreted with great caution. Clinical data regarding the diagnosis of Candida pneumonia are largely anecdotal, with a majority of studies based on autopsy findings.
Jan 26, 2016 · Experts say the crux of the problem is that sepsis can have a number of faces. In some cases, it can be very obvious that a patient has low blood pressure and a high temperature. And patients ...
May 8, 2021 · Medications used to treat NTM infection can be difficult for patients to tolerate, and prolonged courses of anti-mycobacterial therapy are often required for adequate suppression or eradication. Herein, we review different NTM syndromes, appropriate diagnostic tests, and treatment regimens.
The term “septic shock” is used to describe what’s happening when a person’s blood pressure is low, oxygen delivery to vital organs is compromised, and the threat of death is imminent. About 1.7 million U.S. adult cases of sepsis occur each year, and nearly 270,000 die from the condition. Sepsis can be difficult to diagnose immediately ...
Mar 18, 2020 · For patients at risk of EBV-related lymphoproliferative disorders and EBV-related malignancies, the detection of EBV-DNA by molecular techniques is valuable for diagnosis and follow-up treatment . Because the onset of symptoms in IM is often hidden up to the fifth day of disease, there is a paucity of details regarding virus–host interactions.
